NCT02525016

Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Hospices Civils de Lyon · Academic / Other
• Sex: All
• Age: 18 Years – 68 Years
• Healthy volunteers: Not accepted

Summary

Intravenous lidocaine is efficient for management of post operative pain in abdominal surgery. As previously published in literature the investigators use it during bariatric surgery. Nevertheless plasmatic concentration of lidocaine is unknown in this population, despite a widespread use. Investigators propose in this work to bring an objective proof that administration of lidocaine based on a modified body weight is safe. Intravenous administration concerned the peri operative period. A total of six samples are taken for each patient. Investigators get approbation of local ethic committee for this work.

Conditions

• Obesity
• Bariatric Surgery

Interventions

Type	Name	Description
BIOLOGICAL	Blood sampling
DRUG	Lidocaine

Timeline

• Start date: 2015-09-01
• Primary completion: 2016-05-01
• Completion: 2016-06-01
• First posted: 2015-08-17
• Last updated: 2025-12-19

Locations

1 site across 1 country: France